Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and
used for ritual purposes by the indigenous populations of the Amazon. The use of a variation …

Background Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom
species. Recent studies have assessed the therapeutic potential of psilocybin for various …

Psychedelic drugs have a long history of use in healing ceremonies, but despite renewed
interest in their therapeutic potential, we continue to know very little about how they work in the …

Predicting the distribution of endangered species from habitat data is frequently perceived
to be a useful technique. Models that predict the presence or absence of a species are …

Assessment of minimal residual disease (MRD) has acquired a prominent position in European
treatment protocols for patients with acute lymphoblastic leukemia (ALL), on the basis of …

Rationale Recent clinical trials are reporting marked improvements in mental health outcomes
with psychedelic drug-assisted psychotherapy. Objectives Here, we report on safety and …

Lysergic acid diethylamide (LSD) is the prototypical psychedelic drug, but its effects on the
human brain have never been studied before with modern neuroimaging. Here, three …

Community-based studies suggest that cannabis products that are high in Δ 9 -tetrahydrocannabinol
(THC) but low in cannabidiol (CBD) are particularly hazardous for mental health. …

Psychedelic drugs produce profound changes in consciousness, but the underlying
neurobiological mechanisms for this remain unclear. Spontaneous and induced oscillatory activity …

Lysergic acid diethylamide (LSD) is a non-selective serotonin-receptor agonist that was first
synthesized in 1938 and identified as (potently) psychoactive in 1943. Psychedelics have …